PATLiSci – Probe Array Technology for Life Sciences Harry Heinzelmann VP Nanotechnology & Life Sciences Zurich, April 2012 PATLiSci – Probe Array Technology for Life…

1. Chemotherapyvs. Targeted Therapy James J Lechner, MD Medical DirectorProvidence Regional Cancer System 2. The Role of Systemic Therapy• Treatment of the whole body•…

Slide 1Dr Sarah J Johnson Consultant Cyto/histopathologist Newcastle upon Tyne Slide 2 This talk Overview of molecular abnormalities in thyroid lesions Potential value Our…

Slide 1IHE APSR – the German view Gunter Haroske 1 & Thomas Schrader 2,3 Institute für Pathologie KH Dresden-Friedrichstadt 1 HU Berlin Charite 2 FH Brandenburg 3…

1. ASCO 2015 maintrac® circulating tumor cells 2. S Vemurafenib to eliminate BRAF-mutated circulating melanoma tumor cells from blood of patients with malignant melanoma…

Slide 1 Individualizing Therapy for Gastrointestinal Malignancies 2010 Update Thomas J. Semrad MD, MAS Assistant Professor of Medicine UC Davis Cancer Center Slide 2 Disclosure…

Slide 1 Emerging Concepts in the Workup of Melanoma APMG Pathologist, MD FCAP Slide 2 Melanoma Leading cause of death from skin disease ~50% harbor a mutation in the BRAF…

Part II – Melanoma: Novel Pathways and Agents Tuesday, June 21, 2011 7:30 PM – 8:30 PM ET RTP TV: An 8-Part Live CME Webcast Series Keith T Flaherty, MD Associate Professor…

Predicting Safety and Efficacy of Treatment for Colon Cancer Clinical Science Symposium Towards Personalized Medicine: Trials and Technologies That Will Lead to Individualized…

Aiming at the Wrong Target? Discussion of Abstracts CRA3507 (Alberts) and 3508 (Goldberg) Louis M. Weiner, MD Lombardi Comprehensive Cancer Center Georgetown University Medical…